258 related articles for article (PubMed ID: 18157895)
41. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties?
Brurok H; Ardenkjaer-Larsen JH; Hansson G; Skarra S; Berg K; Karlsson JO; Laursen I; Jynge P
Biochem Biophys Res Commun; 1999 Jan; 254(3):768-72. PubMed ID: 9920816
[TBL] [Abstract][Full Text] [Related]
42. [MnDPDP--contrast medium with protective effect in acute myocardial infarction].
Hemmingsson A
Lakartidningen; 2002 Oct; 99(40):3955-6. PubMed ID: 12422752
[No Abstract] [Full Text] [Related]
43. [Manganese enhanced magnetic resonance imaging for tracing corticospinal tracts in rat brain using 7.0 T MRI].
Gao GJ; Wen S; Yang T; Dai F; Wu M; Zang FC; An YL; Tan ZB
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):269-71. PubMed ID: 20356544
[TBL] [Abstract][Full Text] [Related]
44. Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts.
Brurok H; Skoglund T; Berg K; Skarra S; Karlsson JO; Jynge P
NMR Biomed; 1999 Oct; 12(6):364-72. PubMed ID: 10516618
[TBL] [Abstract][Full Text] [Related]
45. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit.
Grant D; Blazak WF; Brown GL
Acta Radiol; 1997 Jul; 38(4 Pt 2):759-69. PubMed ID: 9245972
[TBL] [Abstract][Full Text] [Related]
46. An apparent unidirectional influx constant for manganese as a measure of myocardial calcium channel activity.
Skjold A; Kristoffersen A; Vangberg TR; Haraldseth O; Jynge P; Larsson HB
J Magn Reson Imaging; 2006 Nov; 24(5):1047-55. PubMed ID: 17024667
[TBL] [Abstract][Full Text] [Related]
47. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
[TBL] [Abstract][Full Text] [Related]
48. Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model.
Larson AC; Rhee TK; Deng J; Wang D; Sato KT; Salem R; Paunesku T; Woloschak G; Mulcahy MF; Li D; Omary RA
J Magn Reson Imaging; 2006 Jul; 24(1):242-7. PubMed ID: 16758469
[TBL] [Abstract][Full Text] [Related]
49. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies.
Rummeny EJ; Torres CG; Kurdziel JC; Nilsen G; Op de Beeck B; Lundby B
Acta Radiol; 1997 Jul; 38(4 Pt 2):638-42. PubMed ID: 9245957
[TBL] [Abstract][Full Text] [Related]
50. Mapping of the habenulo-interpeduncular pathway in living mice using manganese-enhanced 3D MRI.
Watanabe T; Radulovic J; Boretius S; Frahm J; Michaelis T
Magn Reson Imaging; 2006 Apr; 24(3):209-15. PubMed ID: 16563949
[TBL] [Abstract][Full Text] [Related]
51. Developmental toxicity study of mangafodipir trisodium injection (MnDPDP) in New Zealand white rabbits.
Blazak WF; Brown GL; Gray TJ; Treinen KA; Denny KH
Fundam Appl Toxicol; 1996 Sep; 33(1):11-5. PubMed ID: 8812204
[TBL] [Abstract][Full Text] [Related]
52. Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
Burkill GJ; Mannion EM; Healy JC
Clin Radiol; 2001 Jan; 56(1):67-71. PubMed ID: 11162701
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study.
Wang C; Ahlström H; Ekholm S; Fagertun H; Hellström M; Hemmingsson A; Holtås S; Isberg B; Jonnson E; Lönnemark-Magnusson M; McGill S; Wallengren NO; Westman L
Acta Radiol; 1997 Jul; 38(4 Pt 2):643-9. PubMed ID: 9245958
[TBL] [Abstract][Full Text] [Related]
54. Manganese dipyridoxyl diphosphate. Effect of dose, time, and pulse sequence on hepatic enhancement in rats.
Nelson RC; Chezmar JL; Newberry LB; Malko JA; Gedgaudas-McClees RK; Bernardino ME
Invest Radiol; 1991 Jun; 26(6):569-73. PubMed ID: 1907259
[TBL] [Abstract][Full Text] [Related]
55. Uptake of MnCl2 and mangafodipir trisodium in the myocardium: a magnetic resonance imaging study in pigs.
Eriksson R; Johansson L; Bjerner T; Briley Saebo K; Ahlström H
J Magn Reson Imaging; 2004 May; 19(5):564-9. PubMed ID: 15112305
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the retina and optic nerve in a rat model of chronic glaucoma using in vivo manganese-enhanced magnetic resonance imaging.
Chan KC; Fu QL; Hui ES; So KF; Wu EX
Neuroimage; 2008 Apr; 40(3):1166-74. PubMed ID: 18272401
[TBL] [Abstract][Full Text] [Related]
57. Cardiovascular safety of MnDPDP and MnCl2.
Jynge P; Brurok H; Asplund A; Towart R; Refsum H; Karlsson JO
Acta Radiol; 1997 Jul; 38(4 Pt 2):740-9. PubMed ID: 9245970
[TBL] [Abstract][Full Text] [Related]
58. MnDPDP-enhanced magnetization transfer MR imaging: implications for effective liver imaging.
Halavaara J; Abo-Ramadan U; Markkola A; Aronen H; Häkkinen AM
Magn Reson Imaging; 2003 Jan; 21(1):47-50. PubMed ID: 12620545
[TBL] [Abstract][Full Text] [Related]
59. Free-breathing high-spatial-resolution delayed contrast-enhanced three-dimensional viability MR imaging of the myocardium at 3.0 T: a feasibility study.
Amano Y; Matsumura Y; Kumita S
J Magn Reson Imaging; 2008 Dec; 28(6):1361-7. PubMed ID: 19025943
[TBL] [Abstract][Full Text] [Related]
60. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
